Not applicableStudy completedNCT01282762
What this trial is testing
Long-Term Study on Safety and Immunogenicity of HEPLISAV™ and Engerix-B® in Adults With Chronic Kidney Disease
Who this might be right for
Chronic Kidney Disease
Dynavax Technologies Corporation 147